Domov › Rak (vse vrste) › Virginia › Arlington
Klinične študije za Rak (vse vrste) v Arlington, VA
48 študij za Rak (vse vrste) išče udeležence na lokacijah v Arlington in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Vključevanje udeležencevFaza 3
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 2/3
- Virginia Cancer Specialists - Fairfax /ID# 275071, Fairfax · 11 mi stran
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Vključevanje udeležencevFaza 1/2
- NEXT Virginia, Fairfax · 11 mi stran
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
Vključevanje udeležencevFaza 2
- Virginia Cancer Specialists ( Site 1102), Fairfax · 11 mi stran
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Vključevanje udeležencevFaza 2
- Next Virginia /ID# 279684, Fairfax · 11 mi stran
A Study of ASP3082 in Adults With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi stran
REC-7735 in Participants With Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT Virginia, Fairfax · 11 mi stran
A Study of PHN-012 in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- PHN-012-001 Site, Fairfax · 11 mi stran
Registry Study for Radiation Therapy Outcomes
Vključevanje udeležencevOpazovalna študija
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology, Fairfax · 11 mi stran
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Vključevanje udeležencevFaza 3
- Inova Schar Cancer Institute Clinical Trials, Fairfax · 11 mi stran
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Virginia Cancer Specialists - Fairfax /ID# 280710, Fairfax · 11 mi stran
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Vključevanje udeležencevFaza 2
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi stran
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Vključevanje udeležencevFaza 1
- NEXT Virginia ( Site 0054), Fairfax · 11 mi stran
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Vključevanje udeležencevFaza 1
- Investigational Site number: 404, Fairfax · 11 mi stran
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Vključevanje udeležencevFaza 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi stran
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology, Fairfax · 11 mi stran
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- USO - Virginia Cancer Specialists, Fairfax · 11 mi stran
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Virginia, Fairfax · 11 mi stran
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Vključevanje udeležencevFaza 1
- NEXT Oncology, Fairfax · 11 mi stran
Project: Every Child for Younger Patients With Cancer
Vključevanje udeležencevOpazovalna študija
- Inova Fairfax Hospital, Falls Church · 4 mi stran
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
Vključevanje udeležencevFaza 1
- NEXT Oncology Virginia, Fairfax · 11 mi stran
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology Virginia, Fairfax · 11 mi stran
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Vključevanje udeležencevFaza 2
- 522, Fairfax · 11 mi stran
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Virginia Cancer Specialists, Fairfax · 11 mi stran
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Vključevanje udeležencevFaza 1
- Virginia Cancer Specialists - Fairfax /ID# 268559, Fairfax · 11 mi stran
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Vključevanje udeležencevFaza 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax · 11 mi stran
- Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax · 11 mi stran
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi stran
Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Vključevanje udeležencevFaza 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi stran
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT, Fairfax · 11 mi stran
Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System
Vključevanje udeležencev
- Inova Schar Cancer - Saville Cancer Screening and Prevention Center, Fairfax · 11 mi stran
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Vključevanje udeležencevFaza 1
- Research Site, Fairfax · 11 mi stran
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology Virginia, Fairfax · 11 mi stran
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Virginia, Fairfax · 11 mi stran
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Vključevanje udeležencevFaza 1/2
- NEXT Virginia, Fairfax · 11 mi stran
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology - Virginia, Fairfax · 11 mi stran
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Virginia, Fairfax · 11 mi stran
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology Virginia, Fairfax · 11 mi stran
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Virginia, Fairfax · 11 mi stran
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT Oncology, Fairfax · 11 mi stran
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Virginia, Fairfax · 11 mi stran
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Virigina, Fairfax · 11 mi stran
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Virginia Cancer Specialists, Fairfax · 11 mi stran
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Vključevanje udeležencevFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi stran
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Vključevanje udeležencevFaza 1/2
- NEXT Virginia, Fairfax · 11 mi stran
A Study in Patients With Advanced Cancers
Vključevanje udeležencevFaza 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi stran
Študije za Rak (vse vrste) v drugih mestih
- Houston, TX121 študij
- New York City, NY109 študij
- Boston, MA85 študij
- Los Angeles, CA74 študij
- Nashville, TN65 študij
- Philadelphia, PA59 študij
- Washington, DC58 študij
- Durham, NC58 študij
- Chicago, IL51 študij
- Atlanta, GA49 študij
- Seattle, WA49 študij
- St. Louis, MO46 študij
Druge študije v Arlington
- Nemalicelični pljučni rak104 študij
- Metastatski rak53 študij
- Kolorektalni rak52 študij
- Rak dojke47 študij
- Rak jajčnikov46 študij
- Rak pljuč41 študij
- Rak endometrija39 študij
- Rak trebušne slinavke33 študij
- Ploščatocelični karcinom glave in vratu26 študij
- Mikrocitni rak pljuč23 študij
- Rak želodca20 študij
- Trojno negativni rak dojke20 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.